Occupancy of dopamine D2 and D3 and serotonin 5-HT1A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomography

被引：0

作者：

Nicholas Seneca

Sjoerd J. Finnema

István Laszlovszky

Béla Kiss

Attila Horváth

Gabriella Pásztor

Margó Kapás

István Gyertyán

Sándor Farkas

Robert B. Innis

Christer Halldin

Balázs Gulyás

机构：

[1] Karolinska Institutet,Department of Clinical Neuroscience, Psychiatry Section

[2] Molecular Imaging Branch,undefined

[3] National Institute of Mental Health,undefined

[4] National Institutes of Health,undefined

[5] Gedeon Richter Ltd.,undefined

来源：

Psychopharmacology | 2011年 / 218卷

关键词：

Cariprazine; Positron emission tomography (PET); Nonhuman primate brain; Dopamine D; Dopamine D; Serotonin 5-HT; Receptor occupancy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：579 / 587

页数：8

共 50 条

[21] Evaluation of dopamine D2/D3 and serotonin 5-HT2A receptor occupancy for a novel antipsychotic, lurasidone, in conscious common marmosets using small-animal positron emission tomography
Shunsuke Nakazawa
Chihiro Yokoyama
Naohiro Nishimura
Tomoko Horisawa
Akihiro Kawasaki
Hiroshi Mizuma
Hisashi Doi
Hirotaka Onoe
Psychopharmacology, 2013, 225 : 329 - 339
[22] Evaluation of dopamine D2/D3 and serotonin 5-HT2A receptor occupancy for a novel antipsychotic, lurasidone, in conscious common marmosets using small-animal positron emission tomography
Nakazawa, Shunsuke
Yokoyama, Chihiro
Nishimura, Naohiro
Horisawa, Tomoko
Kawasaki, Akihiro
Mizuma, Hiroshi
Doi, Hisashi
Onoe, Hirotaka
PSYCHOPHARMACOLOGY, 2013, 225 (02) : 329 - 339
[23] Dopamine D2 and serotonin 5-HT1A receptors of the brain in processing of pain
Pertovaara, A.
Martikainen, I. K.
Hagelberg, N.
Hirvonen, J.
Scheinin, H.
Hietala, J.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S113 - S113
[24] Occupancy of dopamine D2/D3 receptors in rat brain by endogenous dopamine measured with the agonist positron emission tomography radioligand [11C]MNPA
Seneca, Nicholas
Zoghbi, S. S.
Skinbjerg, M.
Liow, J. S.
Hong, J.
Sibley, D. R.
Pike, V. W.
Halldin, C.
Innis, R. B.
NEUROIMAGE, 2008, 41 : T138 - T138
[25] Bifeprunox: a novel antipsychotic agent with partial agonist properties at dopamine D2 and serotonin 5-HT1A receptors
Wadenberg, Marie-Louise G.
FUTURE NEUROLOGY, 2007, 2 (02) : 153 - 165
[26] ITI-007 demonstrates brain occupancy at serotonin 5-HT2A and dopamine D2 receptors and serotonin transporters using positron emission tomography in healthy volunteers
Robert E. Davis
Kimberly E. Vanover
Yun Zhou
James R. Brašić
Maria Guevara
Blanca Bisuna
Weiguo Ye
Vanessa Raymont
William Willis
Anil Kumar
Lorena Gapasin
D. Ronald Goldwater
Sharon Mates
Dean F. Wong
Psychopharmacology, 2015, 232 : 2863 - 2872
[27] ITI-007 demonstrates brain occupancy at serotonin 5-HT2A and dopamine D2 receptors and serotonin transporters using positron emission tomography in healthy volunteers
Davis, Robert E.
Vanover, Kimberly E.
Zhou, Yun
Brasic, James R.
Guevara, Maria
Bisuna, Blanca
Ye, Weiguo
Raymont, Vanessa
Willis, William
Kumar, Anil
Gapasin, Lorena
Goldwater, D. Ronald
Mates, Sharon
Wong, Dean F.
PSYCHOPHARMACOLOGY, 2015, 232 (15) : 2863 - 2872
[28] Structural analogues of 5-OMe-BPAT:: Synthesis and interactions with dopamine D2, D3, and serotonin 5-HT1A receptors
Homan, EJ
Kroodsma, E
Copinga, S
Unelius, L
Mohell, N
Wikström, HV
Grol, CJ
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (06) : 1111 - 1121
[29] Actions of roxindole at recombinant human dopamine D2, D3 and D4 and serotonin 5-HT1A, 5-HT1B and 5-HT1D receptors
A. Newman-Tancredi
D. Cussac
V. Audinot
M. J. Millan
Naunyn-Schmiedeberg's Archives of Pharmacology, 1999, 359 : 447 - 453
[30] Orally active benzamide antipsychotic agents with affinity for dopamine D2, serotonin 5-HT1A, and adrenergic α1 receptors
Reitz, AB
Baxter, EW
Codd, EE
Davis, CB
Jordan, AD
Maryanoff, BE
Maryanoff, CA
McDonnell, ME
Powell, ET
Renzi, MJ
Schott, MR
Scott, MK
Shank, RP
Vaught, JL
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (12) : 1997 - 2009

← 1 2 3 4 5 →